Atea Pharmaceuticals, Inc.
AVIRAtea Pharmaceuticals, Inc.
NASDAQ
Healthcare
Biotechnology
$5.75
+0.10(1.9%)
52W $2.55 – $6.15
Quick:
10-K
Mar 5, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 5, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Feb 9, 2026 (1 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 8, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Dec 5, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
10-Q
Aug 7, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 7, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 6, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jun 20, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
May 14, 2025 (10 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
May 12, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
May 12, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Apr 23, 2025 (11 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Apr 17, 2025 (11 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Apr 17, 2025 (11 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Apr 1, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 24, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Mar 21, 2025 (1 years ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context